Bio-Technology General (Israel) Ltd.
Records under this name other than the patents Bio-Technology General (Israel) Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Bio-Technology General (Israel) Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,524,885 | Hydrazido derivatives of hyaluronic acid Lapsed on the fee record Ended Sep 3, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 3, 2021 | USPTO record |
| US 7,132,510 | Specific Human Antibodies for Selective Cancer Therapy Lapsed on the fee record Ended Nov 7, 2014 · High confidence | Lapsed on the fee record | Ended Nov 7, 2014 | High confidence |
| US 4,780,414 | Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus Term ended Term ended no later than Oct 25, 2008 · Low confidence | Term ended | Term ended no later than Oct 25, 2008 | Low confidence |
| US 4,784,990 | High molecular weight sodium hyaluronate Term ended Term ended no later than Nov 15, 2008 · Low confidence | Term ended | Term ended no later than Nov 15, 2008 | Low confidence |